158 related articles for article (PubMed ID: 31197692)
21. Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters.
van Beek DJ; Nell S; Verkooijen HM; Borel Rinkes IHM; Valk GD; ; Vriens MR; ;
Surgery; 2021 Apr; 169(4):963-973. PubMed ID: 33220975
[TBL] [Abstract][Full Text] [Related]
22. Long-term Follow-up of Small Nonfunctioning Pancreatic Neuroendocrine Tumors Diagnosed Using Endoscopic Ultrasound-guided Fine-needle Aspiration.
Takano Y; Yamawaki M; Noda J; Azami T; Niiya F; Maruoka N; Yamagami T; Norose T; Ohike N; Nagahama M
Intern Med; 2023 Dec; 62(24):3585-3590. PubMed ID: 37081682
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study.
Sallinen VJ; Le Large TYS; Tieftrunk E; Galeev S; Kovalenko Z; Haugvik SP; Antila A; Franklin O; Martinez-Moneo E; Robinson SM; Panzuto F; Regenet N; Muffatti F; Partelli S; Wiese D; Ruszniewski P; Dousset B; Edwin B; Bartsch DK; Sauvanet A; Falconi M; Ceyhan GO; Gaujoux S;
HPB (Oxford); 2018 Mar; 20(3):251-259. PubMed ID: 28988702
[TBL] [Abstract][Full Text] [Related]
24. Cystic pancreatic neuroendocrine tumors: outcomes of preoperative endosonography-guided fine needle aspiration, and recurrence during long-term follow-up.
Ridtitid W; Halawi H; DeWitt JM; Sherman S; LeBlanc J; McHenry L; Coté GA; Al-Haddad MA
Endoscopy; 2015 Jul; 47(7):617-25. PubMed ID: 25763832
[TBL] [Abstract][Full Text] [Related]
25. Short- and Long-Term Outcomes of Laparoscopic Organ-Sparing Resection for Pancreatic Neuroendocrine Neoplasms.
Zhang RC; Ma J; Mou YP; Zhou YC; Jin WW; Lu C
World J Surg; 2020 Nov; 44(11):3795-3800. PubMed ID: 32700111
[TBL] [Abstract][Full Text] [Related]
26. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
Fernández-Cruz L; Blanco L; Cosa R; Rendón H
World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
[TBL] [Abstract][Full Text] [Related]
27. Resection Versus Observation for Small (≤2 cm) Pancreatic Neuroendocrine Tumors.
Irfan A; Gleason F; Reddy S; Heslin MJ; Rose JB
Am Surg; 2023 Nov; 89(11):4675-4680. PubMed ID: 36134675
[TBL] [Abstract][Full Text] [Related]
28. The role of oncologic resection and enucleation for small pancreatic neuroendocrine tumors.
Altimari M; Abad J; Chawla A
HPB (Oxford); 2021 Oct; 23(10):1533-1540. PubMed ID: 33832835
[TBL] [Abstract][Full Text] [Related]
29. The Role of Surgery for Pancreatic Neuroendocrine Tumors.
Ziogas IA; Schmitz R; Moris D; Vatsaas CJ
Anticancer Res; 2022 Feb; 42(2):629-639. PubMed ID: 35093860
[TBL] [Abstract][Full Text] [Related]
30. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.
Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797
[TBL] [Abstract][Full Text] [Related]
31. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
Teh SH; Deveney C; Sheppard BC
Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
[TBL] [Abstract][Full Text] [Related]
32. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
[TBL] [Abstract][Full Text] [Related]
33. Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors.
Cherenfant J; Talamonti MS; Hall CR; Thurow TA; Gage MK; Stocker SJ; Lapin B; Wang E; Silverstein JC; Mangold K; Odeleye M; Kaul KL; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA
Surgery; 2014 Dec; 156(6):1504-10; discussion 1510-1. PubMed ID: 25456943
[TBL] [Abstract][Full Text] [Related]
34. Basing treatment strategy for non-functional pancreatic neuroendocrine tumors on tumor size.
Kishi Y; Shimada K; Nara S; Esaki M; Hiraoka N; Kosuge T
Ann Surg Oncol; 2014 Sep; 21(9):2882-8. PubMed ID: 24740828
[TBL] [Abstract][Full Text] [Related]
35. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
[TBL] [Abstract][Full Text] [Related]
36. Macrovascular venous invasion of pancreatic neuroendocrine tumours: impact on surgical outcomes and survival.
Addeo P; d'Alessandro A; Averous G; Imperiale A; Faitot F; Goichot B; Bachellier P
HPB (Oxford); 2019 Jun; 21(6):653-661. PubMed ID: 30522946
[TBL] [Abstract][Full Text] [Related]
37. Update on surgical treatment of pancreatic neuroendocrine neoplasms.
D'Haese JG; Tosolini C; Ceyhan GO; Kong B; Esposito I; Michalski CW; Kleeff J
World J Gastroenterol; 2014 Oct; 20(38):13893-8. PubMed ID: 25320524
[TBL] [Abstract][Full Text] [Related]
38. Comparison of EUS-guided ablation and surgical resection for nonfunctioning small pancreatic neuroendocrine tumors: a propensity score-matching study.
So H; Ko SW; Shin SH; Kim EH; Son J; Ha S; Song KB; Kim HJ; Kim MH; Park DH
Gastrointest Endosc; 2023 Apr; 97(4):741-751.e1. PubMed ID: 36400239
[TBL] [Abstract][Full Text] [Related]
39. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
Chen J; Yang Y; Liu Y; Kan H
World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
[TBL] [Abstract][Full Text] [Related]
40.
Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]